Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer

BACKGROUND: Recent randomized controlled trials have failed to show a survival difference between adjuvant chemotherapy (CT) and adjuvant chemoradiotherapy (CRT) in patients with resected gastric cancer (GC). However, a subset of patients with lymph node (LN) positive disease may still benefit from...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Autores principales: Jabo, Brice, Selleck, Matthew J., Morgan, John W., Lum, Sharon S., Bahjri, Khaled, Aljehani, Mayada, Garberoglio, Carlos A., Reeves, Mark E., Namm, Jukes P., Solomon, Naveenraj L., Luca, Fabrizio, Yang, Gary, Senthil, Maheswari
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6087859/
https://ncbi.nlm.nih.gov/pubmed/30151267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.05.12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares